UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of robot‐assisted partial nephrectomy for complex (RENAL scores ≥10) and non‐complex renal tumors: A single‐center experience

International journal of urology, 2021-10, Vol.28 (10), p.1054-1059

2021

Volltextzugriff (PDF)

Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases

Anticancer research, 2024-06, Vol.44 (6), p.2627-2635

2024

Volltextzugriff (PDF)

MP28-07 THE ASSOCIATION OF SOLUBLE PD-L1 AND TREATMENT RESPONSE TO NIVOLUMAB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab

Anticancer research, 2023-02, Vol.43 (2), p.841-847

2023

Volltextzugriff (PDF)

Effects of modifying hinotori™ surgical robot system on perioperative outcome of robot-assisted radical prostatectomy

International journal of urology, 2024-10

2024

Volltextzugriff (PDF)

The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Clinical genitourinary cancer, 2023-10, Vol.21 (5), p.613.e1-613.e6

2023

Volltextzugriff (PDF)

MP18-11 PREDICTIVE EFFICACY OF SERUM SOLUBLE PD-L1 ON PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

Evaluating RB1 and p53 as diagnostic markers in treatment‐related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53

The Prostate, 2024-09, Vol.84 (16), p.1506-1514

2024

Volltextzugriff (PDF)

Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma

Canadian Urological Association journal, 2024-05, Vol.18 (5), p.E162-E166

2024

Volltextzugriff (PDF)

A pathological complete response and adrenal insufficiency in a patient with advanced renal pelvic cancer treated with pembrolizumab

International cancer conference journal, 2024-10, Vol.13 (4), p.391-394

2024

Volltextzugriff (PDF)

Therapeutic outcome of combination therapy using immunecheckpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma

Canadian Urological Association journal, 2024-05, Vol.18 (5), p.E162

2024

Volltextzugriff (PDF)

The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinoma

Oncology letters, 2023-11, Vol.26 (5), p.1, Article 470

2023

Volltextzugriff (PDF)

Initial Experience of Robot Assisted Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction Using the Hinotori Surgical Robot System

The international journal of medical robotics + computer assisted surgery, 2024-10, Vol.20 (5), p.e2673-n/a

2024

Volltextzugriff (PDF)

The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Clinical genitourinary cancer, 2023, Vol.21 (5), p.613.e1-613.e6

2023

Volltextzugriff (PDF)

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan

Haematologica (Roma), 2018-11, Vol.103 (11), p.1835-1842

2018

Volltextzugriff (PDF)

Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients

PloS one, 2021-04, Vol.16 (4), p.e0249449-e0249449

2021

Volltextzugriff (PDF)

Improved fluorescent labeling of chitin oligomers: Chitinolytic properties of acidic mammalian chitinase under somatic tissue pH conditions

Carbohydrate polymers, 2017-05, Vol.164, p.145-153

2017

Volltextzugriff (PDF)

Antipruritic effect of the topical phosphodiesterase 4 inhibitor E6005 ameliorates skin lesions in a mouse atopic dermatitis model

The Journal of pharmacology and experimental therapeutics, 2013-07, Vol.346 (1), p.105-112

2013

Volltextzugriff (PDF)

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

Journal of Virology, 2006-05, Vol.80 (9), p.4510-4520

2006

Volltextzugriff (PDF)

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

Hepatology international, 2022-02, Vol.16 (1), p.68-80

2022

Volltextzugriff (PDF)

Effect of the phosphodiesterase 4 inhibitor E6005 on nerve growth factor elevation in irritated skin of NC/Nga mice

Journal of dermatological science, 2014-12, Vol.76 (3), p.263-264

2014

Volltextzugriff (PDF)

Two-Year Consolidation By Nilotinib Is Associated with Successful Treatment Free Remission in Chronic Myeloid Leukemia with MR4.5: Subgroup Analysis from STAT2 Trial in Japan

Blood, 2016-12, Vol.128 (22), p.1889-1889

2016

Volltextzugriff (PDF)

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

Hepatology international, 2022-02, Vol.16 (1), p.68-80

2022

Volltextzugriff (PDF)

A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves

Experimental dermatology, 2015-03, Vol.24 (3), p.215-216

2015

Volltextzugriff (PDF)

Esophageal Cancer Patients Have a High Incidence of Severe Periodontitis and Preoperative Dental Care Reduces the Likelihood of Severe Pneumonia after Esophagectomy

Digestive surgery, 2016-01, Vol.33 (6), p.495-502

2016

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

PublikationsformTagungsberichte

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(49)
Berichte
(1)

Sprache

Englisch
(45)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Comparison of robot‐assisted partial nephrectomy for complex (RENAL scores ≥10) and non‐complex renal tumors: A single‐center experience

Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases

MP28-07 THE ASSOCIATION OF SOLUBLE PD-L1 AND TREATMENT RESPONSE TO NIVOLUMAB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab

Effects of modifying hinotori™ surgical robot system on perioperative outcome of robot-assisted radical prostatectomy

The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

MP18-11 PREDICTIVE EFFICACY OF SERUM SOLUBLE PD-L1 ON PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB

Evaluating RB1 and p53 as diagnostic markers in treatment‐related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53

Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma

A pathological complete response and adrenal insufficiency in a patient with advanced renal pelvic cancer treated with pembrolizumab

Therapeutic outcome of combination therapy using immunecheckpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma

The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinoma

Initial Experience of Robot Assisted Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction Using the Hinotori Surgical Robot System

The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan

Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients

Improved fluorescent labeling of chitin oligomers: Chitinolytic properties of acidic mammalian chitinase under somatic tissue pH conditions

Antipruritic effect of the topical phosphodiesterase 4 inhibitor E6005 ameliorates skin lesions in a mouse atopic dermatitis model

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

Effect of the phosphodiesterase 4 inhibitor E6005 on nerve growth factor elevation in irritated skin of NC/Nga mice

Two-Year Consolidation By Nilotinib Is Associated with Successful Treatment Free Remission in Chronic Myeloid Leukemia with MR4.5: Subgroup Analysis from STAT2 Trial in Japan

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves

Esophageal Cancer Patients Have a High Incidence of Severe Periodontitis and Preoperative Dental Care Reduces the Likelihood of Severe Pneumonia after Esophagectomy

Aktive Filter

Suchergebnisse filtern